BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19647592)

  • 1. Women's health in rural China.
    Lancet; 2009 Aug; 374(9687):358. PubMed ID: 19647592
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary care for women with intellectual disabilities.
    Wilkinson JE; Cerreto MC
    J Am Board Fam Med; 2008; 21(3):215-22. PubMed ID: 18467533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of DDT on women's health in Bangladesh: escalating breast cancer risk and disturbing menstrual cycle.
    Subah Z; Ryu JH
    Front Public Health; 2024; 12():1309499. PubMed ID: 38410669
    [No Abstract]   [Full Text] [Related]  

  • 4. Cervical cancer prevention in China: where are we now, and what's next?
    Yan H; Wang Q; Qiao Y
    Cancer Biol Med; 2024 Jan; 21(3):213-7. PubMed ID: 38172555
    [No Abstract]   [Full Text] [Related]  

  • 5. "We can't expect much": Childbearing women's 'horizon of expectations' of the health system in rural Vietnam.
    Lakin K; Ha DT; Mirzoev T; Ha BTT; Agyepong IA; Kane S
    Health Place; 2024 Jan; 85():103166. PubMed ID: 38101200
    [No Abstract]   [Full Text] [Related]  

  • 6. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
    Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
    Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Chen J; Zhang R; Xu W; Bai L; Hu D; Nie Y; Xiang R; Kang D; Shi QL
    Cureus; 2024 Mar; 16(3):e55930. PubMed ID: 38601389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of artificial intelligence-assisted liquid-based cytology testing for cervical cancer screening in China.
    Shen M; Zou Z; Bao H; Fairley CK; Canfell K; Ong JJ; Hocking J; Chow EPF; Zhuang G; Wang L; Zhang L
    Lancet Reg Health West Pac; 2023 May; 34():100726. PubMed ID: 37283979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in rate and socioeconomic inequality of cervical cancer screening in northeastern China from 2013 to 2018.
    Liu Y; Guo J; Zhu G; Zhang B; Feng XL
    Front Med (Lausanne); 2022; 9():913361. PubMed ID: 36275788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. At what age should the Uyghur minority initiate cervical cancer screening if screened using careHPV.
    Abulizi G; Mijiti P; Naizhaer G; Tuerxun G; Abuduxikuer G; Zhang YY; Li H; Abulimiti T; Abudurexiti G; Aierken K; Lu L; Maimaiti A
    Cancer Med; 2021 Dec; 10(24):9022-9029. PubMed ID: 34816621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study.
    Zhao Y; Bao H; Ma L; Song B; Di J; Wang L; Gao Y; Ren W; Wang S; Wang HJ; Wu J
    BMC Med; 2021 Jul; 19(1):164. PubMed ID: 34261463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.
    Bao H; Sun X; Zhang Y; Pang B; Li H; Zhou L; Wu F; Cao D; Wang J; Turic B; Wang L
    Cancer Med; 2020 Sep; 9(18):6896-6906. PubMed ID: 32697872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study.
    You D; Han L; Li L; Hu J; Zimet GD; Alias H; Danaee M; Cai L; Zeng F; Wong LP
    Vaccines (Basel); 2020 Jan; 8(1):. PubMed ID: 31963370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on service capacity of primary medical and health institutions for cervical cancer screening in urban and rural areas in China.
    Li Y; Ma L; Yang C; Chen Z; Zhao Y; Dang L; Lang J; Qiao Y
    Chin J Cancer Res; 2019 Oct; 31(5):838-848. PubMed ID: 31814687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.
    Wei M; Zhou W; Bi Y; Wang H; Liu Y; Zhang ZJ
    J Gen Intern Med; 2019 Feb; 34(2):281-284. PubMed ID: 30484099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and distribution of human papillomavirus genotypes among women with high-grade squamous intraepithelial lesion and invasive cervical cancer in Ganzhou, China.
    Liao L; Cheng H; Zeng F; Zhou W; Ding Y
    J Clin Lab Anal; 2019 Mar; 33(3):e22708. PubMed ID: 30390349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China.
    Ruan G; Song Y; Dong B; Mao X; Lin F; Kang Y; Xu S; Chen X; Wu Q; Sun P
    Cancer Manag Res; 2018; 10():3227-3235. PubMed ID: 30233239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant variations in the cervical cancer screening rate in China by individual-level and geographical measures of socioeconomic status: a multilevel model analysis of a nationally representative survey dataset.
    Bao H; Zhang L; Wang L; Zhang M; Zhao Z; Fang L; Cong S; Zhou M; Wang L
    Cancer Med; 2018 May; 7(5):2089-2100. PubMed ID: 29573569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness analysis of different types of human papillomavirus vaccination combined with a cervical cancer screening program in mainland China.
    Mo X; Gai Tobe R; Wang L; Liu X; Wu B; Luo H; Nagata C; Mori R; Nakayama T
    BMC Infect Dis; 2017 Jul; 17(1):502. PubMed ID: 28720082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VIA/VILI is more suitable for cervical cancer prevention in Chinese poverty-stricken region: a health economic evaluation.
    Xie Y; Tan X; Shao H; Liu Q; Tou J; Zhang Y; Luo Q; Xiang Q
    BMC Public Health; 2017 Jan; 17(1):118. PubMed ID: 28122530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.